Kestine (Ebastine)

Ebastine is a selective peripheral H1‑receptor antagonist. It binds to H1 receptors on mast cells and other tissues, preventing histamine from activating the cascade that causes vasodilation, increased permeability, and nerve irritation, thereby reducing typical allergy symptoms.

The dose of Kestine is determined by the prescribing clinician based on the patient’s age, severity of symptoms, and any relevant medical conditions. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for ebastine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To request Kestine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with first‑generation antihistamines, ebastine (Kestine) offers similar efficacy for allergic symptoms but with a lower risk of sedation because it does not readily cross the blood‑brain barrier. It is also more selective than some second‑generation agents, reducing off‑target effects.

Kestine should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and keep out of reach of children.

Kestine is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to ensure optimal absorption.

Serious but rare risks include cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, and hepatic injury. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, chest pain, or jaundice.

Kestine is contraindicated in individuals with known hypersensitivity to ebastine or any of the tablet excipients. Caution is also advised for patients with severe hepatic impairment, uncontrolled cardiac disease, or those taking strong CYP3A4 inhibitors without medical supervision.